Review summary
Evoprolium is a broker established within the last 2-5 years, with its operational base registered in Cyprus. The broker exhibits a very low overall assessment score of 1.29, which is primarily attributed to a complete absence of recognized regulatory oversight and valid forex trading licenses. The entity's business scope has been flagged as suspicious, and it operates without any form of authoritative financial regulation, placing it in the category of an unregulated offshore entity. Potential investors should be aware that engaging with such platforms carries inherent risks due to the lack of investor protection mechanisms typically enforced by regulatory bodies. In summary, Evoprolium presents a profile of an unregulated firm with significant questions surrounding its operational legitimacy and compliance framework. Note: Regulatory status, trading conditions, and risk assessments may vary by jurisdiction. The WikiFX score reflects currently available information.Please verify all entity details independently before trading. (Updated: 2026-04-11)
